Fructosamine as an Alternative Glycemic Marker

Primary Clinical Indications

The American Diabetes Association recommends fructosamine as an alternative glycemic marker when HbA1c testing cannot be measured or may not be useful, particularly in patients with hemolytic anemias, end-stage kidney disease, or frequent blood transfusions 1, 2, 3
In patients with end-stage kidney disease on hemodialysis, HbA1c can be falsely low due to anemia, erythropoietin-stimulating agents, and reduced erythrocyte lifespan, making fructosamine a useful alternative 4

Fructosamine reflects glycemic control over the preceding 2-3 weeks, compared to HbA1c which reflects 2-3 months of glycemia, making it useful for documenting short-term changes in glycemic status 1, 2, 3, 5, 6
The shorter timeframe of fructosamine makes it useful for monitoring glycemic control in patients with diabetic pregnancy or after major changes in therapy 1, 2, 3, 6

Fructosamine measures total glycated serum proteins, predominantly albumin, through non-enzymatic glycation, forming stable ketoamines 1, 5
The turnover of human serum albumin has a half-life of 14-20 days, explaining the shorter monitoring window of fructosamine compared to HbA1c 1, 2, 3, 6, 7

Fructosamine values can vary with changes in synthesis or clearance of serum proteins that occur with acute systemic illness or liver disease 1, 2, 3
In patients with end-stage kidney disease, fructosamine can be inaccurate due to hypoalbuminemia, which is common in this population 4
There is ongoing debate about whether fructosamine assays should be corrected for serum protein or albumin concentrations 1, 2

The 2024 ADA Standards recommend using alternative approaches to monitoring glycemic status, including fructosamine, in people with conditions that interfere with HbA1c interpretation 5
Fructosamine should not be considered equivalent to HbA1c, as it only indicates glycemic control over a short period, and has not been shown to be related to the risk of development or progression of chronic complications of diabetes 1, 2